(Q48021282)

7 February 2018

title

Sibutramine promotes amygdala activity under fasting conditions in obese women (English)

1 reference

7 February 2018

0 references

1 reference

8

Thomas F Münte

1 reference

7 February 2018

Kerstin M. Oltmanns

1

object named as

Kerstin M Oltmanns

1 reference

7 February 2018

author name string

Marcus Heldmann

2

1 reference

7 February 2018

Susanne Daul

3

1 reference

7 February 2018

Silke Klose

4

1 reference

7 February 2018

Michael Rotte

5

1 reference

7 February 2018

Michael Schäfer

6

1 reference

7 February 2018

Hans-Jochen Heinze

7

1 reference

7 February 2018

Hendrik Lehnert

9

1 reference

7 February 2018

publication date

24 December 2011

1 reference

7 February 2018

number of pages

8

1 reference

inferred from page(s)

published in

Psychopharmacology

1 reference

7 February 2018

volume

221

1 reference

7 February 2018

issue

4

1 reference

7 February 2018

page(s)

693-700

1 reference

7 February 2018

The brain, appetite, and obesity

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2615-7

Differences between liking and wanting signals in the human brain and relations with cognitive dietary restraint and body mass index

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2615-7

Sibutramine--another flawed diet pill

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2615-7

Sensory experience of food and obesity: a positron emission tomography study of the brain regions affected by tasting a liquid meal after a prolonged fast

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2615-7

Dietary restraint violations influence reward responses in nucleus accumbens and amygdala

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2615-7

Distinct modulatory effects of satiety and sibutramine on brain responses to food images in humans: a double dissociation across hypothalamus, amygdala, and ventral striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2615-7

Effect of satiation on brain activity in obese and lean women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2615-7

Visualization of group inference data in functional neuroimaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2615-7

Fasting biases brain reward systems towards high-calorie foods

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2615-7

Sympathetic vasomotor tone determines blood pressure response to long-term sibutramine treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2615-7

Effect of sibutramine on weight maintenance after weight loss: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2615-7

Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2615-7

Ventral striatal control of appetitive motivation: role in ingestive behavior and reward-related learning

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2615-7

Cortical and limbic activation during viewing of high- versus low-calorie foods

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2615-7

Affect modulates appetite-related brain activity to images of food.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2615-7

Hunger selectively modulates corticolimbic activation to food stimuli in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2615-7

Sibutramine. A review of its contribution to the management of obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2615-7

A randomized trial of sibutramine in the management of obese type 2 diabetic patients treated with metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2615-7

Hunger is the best spice: an fMRI study of the effects of attention, hunger and calorie content on food reward processing in the amygdala and orbitofrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2615-7

Effective connectivity of a reward network in obese women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2615-7

Widespread reward-system activation in obese women in response to pictures of high-calorie foods.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2615-7

Neuroanatomical correlates of hunger and satiation in humans using positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2615-7

Automated Anatomical Labeling of Activations in SPM Using a Macroscopic Anatomical Parcellation of the MNI MRI Single-Subject Brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2615-7

Persistence of abnormal neural responses to a meal in postobese individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2615-7

Sibutramine reduces food intake in non-dieting women with obesity

21 January 2018

1 reference

12 December 2020

Sibutramine therapy in obese women--effects on plasma neuropeptide Y (NPY), insulin, leptin and beta-endorphin concentrations.

1 reference

12 December 2020

How does sibutramine work?

1 reference

12 December 2020

Modalities of the food intake-reducing effect of sibutramine in humans

1 reference

12 December 2020

Basal amygdaloid complex afferents to the rat nucleus accumbens are compartmentally organized.

1 reference

12 December 2020

Personality Predicts the Brain's Response to Viewing Appetizing Foods: The Neural Basis of a Risk Factor for Overeating

1 reference

12 December 2020

Sibutramine: its mode of action and efficacy

1 reference

12 December 2020

10.1007/S00213-011-2615-7

Identifiers

DOI

1 reference

7 February 2018

1 reference

7 February 2018